Organization
Jiangsu Vcare Pharmaceutical Technology
9 clinical trials
Clinical trial
Food Effect Study on the Pharmacokinetics of VC004 Capsules in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2022-10-28
Clinical trial
A Pharmacokinetic/Pharmacodynamic Study to Evaluate the Effect of Omeprazole of Vicagrel in Healthy SubjectsStatus: Recruiting, Estimated PCD: 2023-02-01
Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Tablets in Adult Patients With Moderate to Severe Atopic DermatitisStatus: Recruiting, Estimated PCD: 2026-08-23
Clinical trial
A Randomized, Double-blind, Dose-escalating, Placebo-controlled Phase Ib Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.Status: Completed, Estimated PCD: 2023-10-18
Clinical trial
A Phase 1, Open-label, Randomized, Multiple-dose, Crossover Pharmacokinetic/Pharmacodynamic Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 PhenotypesStatus: Completed, Estimated PCD: 2022-11-03
Clinical trial
Single-arm, Open, Multi-center Phase I/Phase II Clinical Study to Assess the Safety, Tolerability, Pharmacokinetic and Effectiveness of VC004Status: Recruiting, Estimated PCD: 2024-01-31
Clinical trial
Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients With Mild to Moderate Atopic DermatitisStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
Randomized, Double-blind, Multiple-dose Escalation, Placebo-controlled Phase I Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Pharmacodynamics of VC005 Tablets in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-11-02
Clinical trial
A Multicenter, Randomized, Double-blind, Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.Status: Recruiting, Estimated PCD: 2026-04-23